Call for papers - Gestational diabetes: insights from endocrinology

Guest Editors

Burak Bayraktar, MD, Ankara Etlik City Hospital, Türkiye
Maisa N. Feghali, MD, MSCR, University of Pittsburgh, USA
Paweł Jan Stanirowski, MD, PhD, Medical University of Warsaw, Poland

Submission Status: Open | Submission Deadline: 25 August 2025

BMC Endocrine Disorders is calling for submissions to our Collection on Gestational diabetes. This Collection invites research that explores the multifaceted aspects of gestational diabetes mellitus (GDM). BMC Endocrine Disorders welcomes submissions that investigate the pathophysiology, management strategies, and long-term implications of GDM, aiming to enhance our understanding and improve health outcomes for mothers and their children.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Heath & Well-being.

Submit to Collection

Meet the Guest Editors

Back to top

Burak Bayraktar, MD, Ankara Etlik City Hospital, Türkiye

Dr Burak Bayraktar is a specialist in Obstetrics and Gynecology with a subspecialty focus in Maternal-Fetal Medicine. He earned his MD from Dokuz Eylul University Faculty of Medicine, then completed his residency in Obstetrics and Gynecology at the University of Health Sciences Izmir Tepecik Training and Research Hospital. Dr Bayraktar pursued further subspecialty training in Maternal-Fetal Medicine at both Ankara Etlik Zubeyde Hanim Women’s Health Teaching and Research Hospital and Ankara Etlik City Hospital. Currently, he serves in the Department of Obstetrics and Gynecology Division of Perinatology at Ankara Etlik City Hospital. Dr Bayraktar is recognized for his expertise in high-risk pregnancies, advanced maternal-fetal ultrasonography, fetal surgery, and perinatal outcomes. His research has significantly contributed to advancements in prenatal and postnatal care as well as fetal monitoring. He also serves as an editor and referee for several reputable journals. Fluent in Turkish and English, with basic proficiency in German, Dr Bayraktar’s professional and academic work continues to shape best practices in maternal and fetal health.

Maisa N. Feghali, MD, MSCR, University of Pittsburgh, USA

Dr Maisa Feghali is an Assistant Professor in the Department of Obstetrics and Gynecology and the division of Maternal Fetal Medicine. She directs the Diabetes in Pregnancy Program at Magee Womens Hospital of UPMC. Her research has examined predictors of treatment response and neonatal adverse outcomes in women with diabetes in pregnancy. Her current work focuses on the variation in the underlying metabolic mechanisms of diabetes in pregnancy and the potential role of individualized therapy.

Paweł Jan Stanirowski, MD, PhD, Medical University of Warsaw, Poland

Dr Paweł J. Stanirowski graduated from the Medical University of Warsaw and obtained his MD degree in 2010. In 2018, he completed specialization in obstetrics and gynecology in the Department of Obstetrics, Gynecology and Oncology, II Faculty of Medicine at the Medical University. In 2021, he became a specialist in maternal-fetal medicine. Currently, he has been working in the 1st Department of Obstetrics and Gynecology at the Medical University of Warsaw as an Assistant Professor - Deputy Director for Medical Affairs. His main research interests focus on the issues of pathophysiology of diabetes in pregnancy, transplacental nutrient transfer in pregnancies complicated by diabetes mellitus and fetal growth disorders, and the utilization of new biomarkers in the assessment of intrauterine fetal growth.

About the Collection

BMC Endocrine Disorders is calling for submissions to our Collection, Gestational diabetes: insights from endocrinology.

Gestational diabetes mellitus (GDM) is a condition characterized by hyperglycemia that develops or is detected for the first time during pregnancy. It affects approximately 5-15% of pregnancies worldwide and is associated with multiple obstetric complications, such as fetal macrosomia, birth trauma and preeclampsia. Furthermore, the effect of GDM extends beyond gestation as it increases the risk of long-term metabolic disorders in both mothers and their offspring.

Understanding the pathophysiology of GDM, including the roles of insulin resistance and gestational weight gain, is crucial for developing effective management strategies. Recent advances in endocrinology have provided insights into the mechanisms underlying GDM, including the impact of maternal adiposity as well as the potential benefits of interventions, such as lifestyle modifications and pharmacotherapy.

Future research in this area holds the promise of developing personalized treatment approaches based on genetic, metabolic, and lifestyle factors. Innovations in continuous glucose monitoring technology and telemedicine may enhance patient engagement and compliance with management plans. Moreover, understanding the long-term implications of GDM on maternal health and fetal development could lead to preventive strategies that mitigate the risk of type 2 diabetes mellitus and other metabolic disorders in later life.

Topics that are welcome include, but are not limited to, the following:

Mechanisms of insulin resistance in GDM
Endocrinopathies associated with GDM development
Impact of gestational weight gain on GDM outcomes
The role of obesity in the pathogenesis of GDM
Screening strategies and diagnostic criteria for early detection of GDM
Effectiveness of lifestyle interventions (e.g., diet and exercise) in preventing and managing GDM
Efficacy of Metformin in managing GDM including short and long-term outcomes
Utility of continuous glucose monitoring in optimizing GDM management
Long-term effects of GDM on maternal and child health

This Collection supports and amplifies research related to SDG 3: Good Health & Well-being.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Gestational diabetes: insights from endocrinology" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.